Stoke Therapeutics (STOK) Free Cash Flow (2018 - 2026)

Stoke Therapeutics' quarterly Free Cash Flow came in at -$60.9 million in Q1 2026, down 146.26% year-on-year from $131.7 million in Q1 2025, and down 99.74% quarter-over-quarter from -$30.5 million in Q4 2025.

Stoke Therapeutics has reported Free Cash Flow for 9 years, with the latest figure at -$60.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Free Cash Flow fell 146.26% year-over-year to -$60.9 million; the trailing twelve-month figure through Mar 2026 stood at -$147.5 million (down 312.72% YoY), and the FY2025 full-year result was $45.1 million, up 151.9% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$60.9 million, down from -$30.5 million in the prior quarter.
  • The five-year high for Free Cash Flow was $131.7 million in Q1 2025, with the low at -$60.9 million in Q1 2026.
  • Average Free Cash Flow over 5 years is -$13.0 million, with a median of -$21.9 million recorded in 2023.
  • Year-over-year, Free Cash Flow plunged 169.2% in 2023 and surged 635.87% in 2025.
  • Tracing STOK's Free Cash Flow over 5 years: stood at -$25.9 million in 2022, then gained by 19.48% to -$20.9 million in 2023, then dropped by 10.61% to -$23.1 million in 2024, then slumped by 32.07% to -$30.5 million in 2025, then slumped by 99.74% to -$60.9 million in 2026.
  • The last three Free Cash Flow figures came in at -$60.9 million (Q1 2026), -$30.5 million (Q4 2025), and -$30.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.29 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 848.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67 Mn
10 Stoke Therapeutics 1.92 Bn 1.92 Bn - -60.92 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -60.92 Mn
Mar 31, 2026 -60.92 Mn
Dec 31, 2025 -30.50 Mn
Dec 31, 2025 -30.50 Mn
Sep 30, 2025 -30.75 Mn
Sep 30, 2025 -30.75 Mn
Jun 30, 2025 -25.32 Mn
Jun 30, 2025 -25.32 Mn
Mar 31, 2025 131.68 Mn
Mar 31, 2025 131.68 Mn
Dec 31, 2024 -23.09 Mn
Dec 31, 2024 -23.09 Mn
Sep 30, 2024 -21.78 Mn
Sep 30, 2024 -21.78 Mn
Jun 30, 2024 -17.47 Mn
Jun 30, 2024 -17.47 Mn
Mar 31, 2024 -24.57 Mn
Mar 31, 2024 -24.57 Mn
Dec 31, 2023 -20.88 Mn
Dec 31, 2023 -20.88 Mn
Sep 30, 2023 -17.65 Mn
Sep 30, 2023 -17.65 Mn
Jun 30, 2023 -22.26 Mn
Jun 30, 2023 -22.26 Mn
Mar 31, 2023 -21.90 Mn
Mar 31, 2023 -21.90 Mn
Dec 31, 2022 -25.93 Mn
Dec 31, 2022 -25.93 Mn
Sep 30, 2022 -20.94 Mn
Sep 30, 2022 -20.94 Mn
Jun 30, 2022 -20.61 Mn
Jun 30, 2022 -20.61 Mn
Mar 31, 2022 31.65 Mn
Mar 31, 2022 31.65 Mn
Dec 31, 2021 -17.42 Mn
Dec 31, 2021 -17.42 Mn
Sep 30, 2021 -14.00 Mn
Sep 30, 2021 -14.00 Mn
Jun 30, 2021 -16.35 Mn
Jun 30, 2021 -16.35 Mn
Mar 31, 2021 -20.34 Mn
Mar 31, 2021 -20.34 Mn
Dec 31, 2020 -9.98 Mn
Dec 31, 2020 -9.98 Mn
Sep 30, 2020 -11.79 Mn
Sep 30, 2020 -11.79 Mn
Jun 30, 2020 -9.08 Mn
Jun 30, 2020 -9.08 Mn
Mar 31, 2020 -11.38 Mn
Mar 31, 2020 -11.38 Mn
Dec 31, 2019 -9.27 Mn
Dec 31, 2019 -9.27 Mn
Sep 30, 2019 -8.88 Mn
Sep 30, 2019 -8.88 Mn
Jun 30, 2019 -6.42 Mn
Jun 30, 2019 -6.42 Mn
Mar 31, 2019 -6.62 Mn
Mar 31, 2019 -6.62 Mn
Dec 31, 2018 -2.69 Mn
Dec 31, 2018 -2.69 Mn
Sep 30, 2018 -3.79 Mn
Sep 30, 2018 -3.79 Mn